Cargando…

SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster

Detalles Bibliográficos
Autores principales: Wang, Qian, Bowen, Anthony, Tam, Anthony R, Valdez, Riccardo, Stoneman, Emily, Mellis, Ian A, Gordon, Aubree, Liu, Lihong, Ho, David D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058662/
https://www.ncbi.nlm.nih.gov/pubmed/37003292
http://dx.doi.org/10.1016/S1473-3099(23)00181-0
_version_ 1785016687283666944
author Wang, Qian
Bowen, Anthony
Tam, Anthony R
Valdez, Riccardo
Stoneman, Emily
Mellis, Ian A
Gordon, Aubree
Liu, Lihong
Ho, David D
author_facet Wang, Qian
Bowen, Anthony
Tam, Anthony R
Valdez, Riccardo
Stoneman, Emily
Mellis, Ian A
Gordon, Aubree
Liu, Lihong
Ho, David D
author_sort Wang, Qian
collection PubMed
description
format Online
Article
Text
id pubmed-10058662
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-100586622023-03-30 SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster Wang, Qian Bowen, Anthony Tam, Anthony R Valdez, Riccardo Stoneman, Emily Mellis, Ian A Gordon, Aubree Liu, Lihong Ho, David D Lancet Infect Dis Correspondence Elsevier Ltd. 2023-05 2023-03-29 /pmc/articles/PMC10058662/ /pubmed/37003292 http://dx.doi.org/10.1016/S1473-3099(23)00181-0 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Wang, Qian
Bowen, Anthony
Tam, Anthony R
Valdez, Riccardo
Stoneman, Emily
Mellis, Ian A
Gordon, Aubree
Liu, Lihong
Ho, David D
SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster
title SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster
title_full SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster
title_fullStr SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster
title_full_unstemmed SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster
title_short SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster
title_sort sars-cov-2 neutralising antibodies after bivalent versus monovalent booster
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058662/
https://www.ncbi.nlm.nih.gov/pubmed/37003292
http://dx.doi.org/10.1016/S1473-3099(23)00181-0
work_keys_str_mv AT wangqian sarscov2neutralisingantibodiesafterbivalentversusmonovalentbooster
AT bowenanthony sarscov2neutralisingantibodiesafterbivalentversusmonovalentbooster
AT tamanthonyr sarscov2neutralisingantibodiesafterbivalentversusmonovalentbooster
AT valdezriccardo sarscov2neutralisingantibodiesafterbivalentversusmonovalentbooster
AT stonemanemily sarscov2neutralisingantibodiesafterbivalentversusmonovalentbooster
AT mellisiana sarscov2neutralisingantibodiesafterbivalentversusmonovalentbooster
AT gordonaubree sarscov2neutralisingantibodiesafterbivalentversusmonovalentbooster
AT liulihong sarscov2neutralisingantibodiesafterbivalentversusmonovalentbooster
AT hodavidd sarscov2neutralisingantibodiesafterbivalentversusmonovalentbooster